Evidence that a prostanoid produced by cyclo-oxygenase-2 enhances contractile responses of the porcine isolated coronary artery following exposure to lipopolysaccharide

British Journal of Anaesthesia

Volumn 98, Issue 3, 2007, Pages 323-330

  Qi, W ^a   Wei, J X ^a   Dorairaj, I ^a   Mahajan, Ravi P ^a   Wilson, V G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Arteries, coronary; Complications, endotoxaemia; Enzymes, cyclo oxygenase

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; ARGININE; CYCLOOXYGENASE 2; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR 1A; INDOMETACIN; LIPOPOLYSACCHARIDE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; POTASSIUM CHLORIDE; PROSTANOID; SUBSTANCE P; UNCLASSIFIED DRUG; ENDOTHELIN A RECEPTOR; PROSTAGLANDIN SYNTHASE INHIBITOR; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; CORONARY ARTERY PRESSURE; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME INDUCTION; IN VITRO STUDY; ISOLATED ARTERY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SWINE; TISSUE CULTURE; ANIMAL; BIOSYNTHESIS; CORONARY BLOOD VESSEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; PHYSIOLOGY; TISSUE CULTURE TECHNIQUE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; CORONARY VESSELS; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPOPOLYSACCHARIDES; MUSCLE, SMOOTH, VASCULAR; POTASSIUM CHLORIDE; RECEPTOR, ENDOTHELIN A; SWINE; TISSUE CULTURE TECHNIQUES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 34247868920     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/ael378     Document Type: Article

References (32)

1. Bishop-Bailey D, Larkin SW, Warner T, et al. Characterization of the induction of nitric oxide synthase and cyclooxygenase in rat aorta in organ culture. Br J Pharmocol 1997; 121: 125-33
2. Woods M, Bishop-Bailey D, Pepper JR, et al. Cytokines and lipopolysaccharide stimulation of endothelin-1 release from human internal mammary artery and saphenous artery smooth muscle cells. J Cardiovasc Pharmacol 1998; 31 (Suppl): S348-S350
3. Annane D, Sanquer S, Sebille V, et al. Compartmentalised inducible nitric oxide synthase activity in septic shock. Lancet 2000; 355: 1143-8
4. Soler M, Camacho M, Vila L. Imidazolineoxyl N-oxide prevents the impairment of vascular contraction caused by interleukin-1β through several mechanisms. J Infect Dis 2003; 188: 927-37
5. Avontuur JA, Boomsma F, van den Meiracker AH, et al. Endothelin-1 and blood pressure after inhibition of nitric oxide synthase in human septic shock. Circulation 1999; 99: 271-5
6. Stoclet JC, Martinez MC, Ohlmann P, et al. Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock. Circulation 1999; 100: 107-12
7. Shibano T, Vanhoutte PM. Induction of NO production by TNFα and lipopolysaccharide in porcine coronary arteries with endothelium. Am J Physiol 1993; 264: H403-H407
8. O'Brien AJ, Wilson AJ, Sibbald R, et al. Temporal variation in endotoxin-induced vascular hyporeactivity in a rat mesenteric organ culture model. Br J Pharmacol 2001; 133: 351-60
9. Thorin-Trescases N, Hamilton CA, Ried JL, et al. Inducible L-arginine/nitric oxide pathway in human internal mammary artery and saphenous vein. Am J Physiol 1995; 268: H1122-H1132
10. Berrazueta JR, Salas E, Amado JA, et al. Induction of nitric oxide synthase in human mammary arteries in vitro. Eur J Pharmacol 1994; 251: 303-5
11. Magder S, Javeshghani D, Cernacek P, et al. Regional distribution of endothelin-1 and endothelin converting enzyme in porcine endotoxaemia. Shock 2001: 16; 320-5
12. Soop A, Albert J, Weitzberg E, et al. Complement activation, endothelin-1 and neuropeptide Y in relation to the cardiovascular response to endotoxin-induced systemic inflammation in healthy volunteers. Acta Anaesthesiol Scand 2004; 48: 74-81
13. Krejci V, Hiltebrand LB, Erni D, et al. Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock. Crit Care Med 2003; 31: 203-10
14. Wanecek M, Rudehill A, Hemsen A, et al. The endothelin receptor antagonist, bosentan, in combination wiih the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock. Crit Care Med 1997; 25: 848-57
15. Wei JX, Wilson VG, Mahajan R. Comparison of the effect of prolonged exposure to LPS or microbial organisms on responses of the porcine isolated coronary artery. Br J Anaesth 2005; 94: 410P
16. Lawrence RN, Clelland C, Beggs D, et al. Differential role of vasoactive prostanoids in porcine and human isolated pulmonary arteries in response to endothelium-dependent relaxants. Br J Pharmacol 1998; 125: 1128-37
17. Seo B, Oemar BS, Siebenmann R, et al. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994; 89: 1203-8
18. Ochi T, Motoyama Y, Goto T. The analgesic effect profile of FR 122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models. Eur J Pharmcol 2000; 391: 49-54
19. Escobales N, Rivera-Correa M, Altieri P, et al. Relationship between NO synthesis, arginine transport and intracellular arginine levels in vascular smooth muscle cells. Amino Acids 2000; 19 451-68
20. Vallence P, Leiper J. Blocking NO synthesis: How, where and why? Nat Rev Drug Dis 2002; 1: 939-50
21. Tsuneyoshi I, Kanmura Y, Yoshimura N. Lipoteichoic acid from Staphylococcus aureus depresses contractile function of human arteries in vitro due to the induction of nitric oxide synthase. Anaesth Analg 1996; 82: 948-53
22. Perez-Vicaino F, Villamor E, Del Pozo BF. Lack of endotoxin-induced hyporesponsiveness to U46619 in isolated neonatal porcine pulmonary but not mesenteric arteries. J Vasc Res 1996; 33: 249-57
23. Mathewson AM, McPhaden AR, Wadsworth RM, et al. The induction and detection in vitro of iNOS in the porcine basilar artery. J Immunol Meth 2003; 279: 163-71
24. Villamor E, Perez-Vizcaino F, Ruiz T, et al. Group B Streptococcus and E. coli LPS-induced NO-dependent hyporesponsiveness to noradrenaline in isolated intrapulmonary arteries of neonatal pigs. Br J Pharmacol 1995; 115: 261-6
25. Jimenez R, Belcher E, Sriskandan S, et al. Role of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle. Proc Natl Acad Sci USA 2005; 102: 4637-42
26. Wood M, Mitchell JA, Wood E, et al.: Endothelin is induced by cytokines in human vascular smooth muscle cells: Evidence for intracellular endothelin-converting enzyme. Mol Pharmacol 1999; 55: 902-9
27. Piepot HA, Groeneveld AB, van Lambalgen AA, et al. The role of inducible nitric oxide synthase in lipopolysaccharide-mediated hyporeactivity to vasoconstrictors differs among isolated rat arteries. Clin Sci 2002; 102: 297-305
28. 2 production in human isolated pulmonary artery smooth muscle cells: concomitant and differential release. FASEB J 1999; 13: 1025-30
29. Bishop-Bailey D, Pepper JR, Larkin SW, et al. Differential induction of cyclooxygenase-2 in human arterial and venous smooth muscle: Role of endogenous prostanoids. Arterioscler Throm Vasc Biol 1998; 18: 1655-61
30. 2 production by human pulmonary artery smooth muscle cells. Prostagladins Leukot Essential Fatty Acid 2000; 62: 369-78
31. Tazzeo T, Miller J, Janssen LJ. Vasoconstrictor responses and underlying mechanisms, to isoprostanes in human and porcine bronchial arterial smooth muscle. Br J Pharmacol 2003; 140: 759-63
32. 2 in porcine coronary artery. J Pharmacol Exp Ther 2003; 305: 1054-60